A fibroblast/macrophage co-culture model to evaluate the biocompatibility of an electrospun Dextran/PLGA scaffold and its potential to induce inflammatory responses
Source abstract
Abstract
Fibroblasts and macrophages are the two major types of cells responding to implanted biomaterials. They play crucial roles in inflammatory responses, host-material interactions and tissue remodeling. However, the synergistic interactions of these two cell types with biomaterials are not fully understood. In this investigation, an in vitro fibroblast/macrophage co-culture system was utilized to examine the biocompatibility and the potential to induce inflammatory responses of an electrospun Dextran/PLGA scaffold. The scaffold did not affect the morphologies, attachments, proliferations and viabilities of both the fibroblasts and macrophages, cultured separately or together. Moreover, it only activated a small subset of the macrophages implicating a low potential to induce either severe acute or chronic inflammatory response. Additionally, fibroblasts played a role in prolonging macrophage activation in the presence of the scaffolds. Using antibody arrays, IL-10, SDF-1, MIP-1 gamma and RANTES were found to be up-regulated when the cells were incubated with the scaffolds. The results of subdermal implantation of the Dextran/PLGA scaffolds confirmed its biocompatibility and low inflammatory potential.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Nerve injury and regeneration
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Xia J T · Biomed. Mater. · 2006 · 1 · 110.1088/1748-6041/1/1/001 ↗
2. Ratner B D · Biomaterials Science: An Introduction to Materials in Medicine · 2004
3. 10.1016/j.jconrel.2005.09.01510.1016/j.jconrel.2005.09.015 ↗
4. 10.1016/j.biomaterials.2006.01.03210.1016/j.biomaterials.2006.01.032 ↗
5. 10.1016/j.biomaterials.2006.08.04110.1016/j.biomaterials.2006.08.041 ↗
6. Jones L C · Biomed. Sci. Instrum. · 2006 · 42 · 223
7. 10.1002/jbm.1028610.1002/jbm.10286 ↗
8. Xia Z · J. Biomed. Mater. Res · 2006 · 79 · 58210.1002/jbm.a.30853 ↗
9. 10.1016/j.biomaterials.2007.12.00510.1016/j.biomaterials.2007.12.005 ↗
10. 10.1021/bm034345w10.1021/bm034345w ↗
11. 10.1189/jlb.040628710.1189/jlb.0406287 ↗
12. Gwinn M R · J. Toxicol. Environ. Health · 2006 · 9 · 2710.1080/15287390500196081 ↗
13. 10.1002/jgm.72410.1002/jgm.724 ↗
14. 10.1016/S0169-409X(00)00054-510.1016/S0169-409X(00)00054-5 ↗
15. 10.1002/(SICI)1097-0215(19970611)71:6<956::AID-IJC8>3.0.CO;2-X10.1002/(SICI)1097-0215(19970611)71:6<956::AID-IJC8>3.0.CO;2-X ↗
16. 10.1097/00006534-199710000-0003510.1097/00006534-199710000-00035 ↗
17. 10.2307/343424210.2307/3434242 ↗
18. 10.1016/j.biomaterials.2005.05.07910.1016/j.biomaterials.2005.05.079 ↗
19. 10.1080/1073119050028990910.1080/10731190500289909 ↗
20. Evonuk E · Am. J. Physiol. · 1967 · 212 · 51410.1152/ajplegacy.1967.212.2.514 ↗
21. Johnston R B · Adv. Exp. Med. Biol. · 1988 · 239 · 6310.1007/978-1-4757-5421-6_7 ↗
22. 10.1146/annurev.iy.02.040184.00143510.1146/annurev.iy.02.040184.001435 ↗
23. 10.1515/bchm3.1990.371.2.102110.1515/bchm3.1990.371.2.1021 ↗
24. 10.1385/IR:26:1-3:09510.1385/IR:26:1-3:095 ↗
25. 10.1016/j.biomaterials.2003.12.00410.1016/j.biomaterials.2003.12.004 ↗
26. 10.1146/annurev.bi.63.070194.00113510.1146/annurev.bi.63.070194.001135 ↗
27. 10.1073/pnas.023708310010.1073/pnas.0237083100 ↗
28. Tomasi A · Free Radicals, Nitric Oxide and Inflammation · 2003 · 264
29. Schaffer M R · J. Immunol. · 1997 · 158 · 237510.4049/jimmunol.158.5.2375 ↗
30. 10.1002/(SICI)1097-4636(199611)32:3<355::AID-JBM8>3.0.CO;2-R10.1002/(SICI)1097-4636(199611)32:3<355::AID-JBM8>3.0.CO;2-R ↗
31. 10.1016/S0142-9612(97)00058-610.1016/S0142-9612(97)00058-6 ↗
32. Thorns M · Biomed. Sci. Instrum. · 2001 · 37 · 287
33. 10.1006/bbrc.2000.260210.1006/bbrc.2000.2602 ↗
34. Ross J A · The Macrophage · 2002
35. 10.1016/j.biomaterials.2010.04.02210.1016/j.biomaterials.2010.04.022 ↗
36. 10.1023/A:100895232978810.1023/A:1008952329788 ↗
37. 10.1097/00062752-200001000-0000810.1097/00062752-200001000-00008 ↗
38. 10.1016/S0002-9440(10)63265-810.1016/S0002-9440(10)63265-8 ↗
39. 10.1146/annurev.immunol.23.021704.11581610.1146/annurev.immunol.23.021704.115816 ↗
40. Sorg C · Chest · 1991 · 100 · 17310.1378/chest.100.3_Supplement.173S ↗
41. 10.1023/A:101855232680810.1023/A:1018552326808 ↗
42. 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H ↗
43. 10.1074/jbc.M60522920010.1074/jbc.M605229200 ↗
44. Taub D D · Ther. Immunol. · 1994 · 1 · 229
45. Fedyk E R · J. Immunol. · 2001 · 166 · 574910.4049/jimmunol.166.9.5749 ↗
46. 10.1038/jid.2008.40510.1038/jid.2008.405 ↗
47. 10.2332/allergolint.10-OA-020710.2332/allergolint.10-OA-0207 ↗
48. 10.1042/0264-6021:347026510.1042/0264-6021:3470265 ↗
49. 10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X ↗